Bone Marrow TransplantationTissue and Organ ProcurementBone MarrowMedical TourismLiving DonorsKidney TransplantationTissue DonorsTransplantation, HomologousLiver TransplantationOrgan TransplantationBone Marrow CellsGraft SurvivalTransplantationWaiting ListsGraft vs Host DiseaseLung TransplantationGraft RejectionTreatment OutcomePostoperative ComplicationsRetrospective StudiesCadaverTime FactorsWhole-Body IrradiationProgram EvaluationTransplantation, AutologousLeukemiaAnemia, AplasticHematopoietic Stem Cell TransplantationCytomegalovirus InfectionsUnited StatesImmunosuppressive AgentsPatient SelectionHistocompatibility TestingRegistriesTransplantation ConditioningHematopoietic Stem CellsImmunosuppressionTransplantsHematologic NeoplasmsHistocompatibilityImmunocompromised HostCyclosporineOpportunistic InfectionsBone Marrow PurgingBone Marrow DiseasesRecurrenceProgram DevelopmentLeukemia, Myeloid, AcuteBone Marrow ExaminationCytomegalovirusTransplantation ChimeraMycosesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoiesisPrecursor Cell Lymphoblastic Leukemia-LymphomaPneumonia, ViralSurvival AnalysisHeart TransplantationAcute DiseaseBone Marrow NeoplasmsBusulfanMice, Inbred C57BLGanciclovirHLA AntigensTransplantation, IsogeneicAntilymphocyte SerumRadiation ChimeraCyclophosphamideFatal OutcomeColony-Forming Units AssayFollow-Up StudiesGraft vs Host ReactionCombined Modality TherapyLymphocyte DepletionHematologic DiseasesNuclear FamilyMyelodysplastic SyndromesSurvival RateHepatic Veno-Occlusive DiseaseRisk FactorsAspergillosisCystitisT-LymphocytesBlood Group IncompatibilityLeukemia, MyeloidTacrolimusPolymerase Chain ReactionTransplantation ImmunologyLymphoma, Non-HodgkinProspective StudiesCell DifferentiationBK VirusDisease-Free SurvivalGovernment ProgramsInfectionMucormycosisLeukocyte CountRemission InductionLymphocyte TransfusionAntiviral Agents